Recently Viewed

News Announcement

Aurobindo Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

10-May-2022 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on May 10 2022 for K Nityananda Reddy

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds